RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 Tryton Two-Stent Strategy Safe, but Did Not Meet Noninferiority Endpoint
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 19
SP 20
OP 21
DO 10.1177/155989771319006
UL http://mdc.sagepub.com/content/13/19/20.abstract
AB The current recommended treatment for patients with coronary bifurcation lesions is main branch stenting with provisional side branch stenting. This approach can lead to suboptimal results in the side branch of true bifurcation lesions, in which disease affects the origin of both branches. The objective of the Prospective Single Blind, Randomized Controlled Study to Evaluate the Safety & Effectiveness of the Tryton Side Branch Stent Used With DES in Treatment of de Novo Bifurcation Lesions in the Main Branch & Side Branch in Native Coronaries [TRYTON; NCT01258972] was to compare clinical and angiographic outcomes of the provisional one-stent strategy with the Tryton bifurcation two-stent approach in patients with true bifurcation lesions.